Curtis Oltmans

2023 - Fulcrum Therapeutics

In 2023, Curtis Oltmans earned a total compensation of $2.3M as Chief Legal Officer at Fulcrum Therapeutics, a 69% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$148,600
Option Awards$1,734,261
Salary$436,800
Total$2,319,661

Oltmans received $1.7M in option awards, accounting for 75% of the total pay in 2023.

Oltmans also received $148.6K in non-equity incentive plan and $436.8K in salary.

Rankings

In 2023, Curtis Oltmans' compensation ranked 423rd out of 2,790 executives tracked by ExecPay. In other words, Oltmans earned more than 84.8% of executives.

ClassificationRankingPercentile
All
423
out of 2,790
85th
Division
Manufacturing
241
out of 1,530
84th
Major group
Chemicals And Allied Products
171
out of 869
80th
Industry group
Drugs
168
out of 832
80th
Industry
Pharmaceutical Preparations
106
out of 597
82nd
Source: SEC filing on April 19, 2024.

Oltmans' colleagues

We found five more compensation records of executives who worked with Curtis Oltmans at Fulcrum Therapeutics in 2023.

2023

Alex Sapir

Fulcrum Therapeutics

Chief Executive Officer

2023

Mel Hayes

Fulcrum Therapeutics

Executive Vice President, Patient Affairs

2023

Alan Musso

Fulcrum Therapeutics

Chief Financial Officer

2023

Bryan Stuart

Fulcrum Therapeutics

Chief Executive Officer

2023

Robert Gould

Fulcrum Therapeutics

Chief Executive Officer

News

In-depth

You may also like